Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
10.10
-0.44 (-4.17%)
Nov 21, 2024, 4:00 PM EST - Market closed
Y-mAbs Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$21.56
Upside
+113.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +127.72% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +117.82% | Nov 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $23 | Buy | Reiterates | $23 | +127.72% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +98.02% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +98.02% | Aug 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +157.43% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $12 → $11 | Sell | Maintains | $12 → $11 | +8.91% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +117.82% | Aug 13, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +147.52% | Aug 13, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +127.72% | Jul 11, 2024 |
| Truist Securities | Truist Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +107.92% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +117.82% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +117.82% | Mar 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +157.43% | Mar 4, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $16 → $26 | Buy | Maintains | $16 → $26 | +157.43% | Mar 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $21 | Strong Buy | Maintains | $11 → $21 | +107.92% | Feb 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.